CANPAN Follow-Up Links THC Dose With Anxiety and Insomnia Improvement in 16 Pancreatic Cancer Patients
A dose-outcome follow-up of the 32-person CANPAN trial had paired symptom data for 16 patients. Higher THC intake was associated with improvements, with four versus 2.1 improved symptoms above versus below 10 mg daily. Dose was not randomized and missing data prevent causal or dosing recommendations.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
academic.oup.com
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://academic.oup.com/oncolo/advance-article/doi/10.1093/oncolo/oyag374/8826188